# Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 7

> **NCT00000358** · PHASE1 · COMPLETED · sponsor: **National Institute on Drug Abuse (NIDA)**

## Conditions studied

- Opioid-Related Disorders
- Substance-Related Disorders

## Interventions

- **DRUG:** Lofexidine

## Key facts

- **NCT ID:** NCT00000358
- **Lead sponsor:** National Institute on Drug Abuse (NIDA)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 0 (—)
- **Last updated:** 2017-01-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00000358

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00000358, "Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 7". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00000358. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*